On the other hand, activated Wnt/β-catenin signaling has been observed only in a small proportion of GBM cells that showed a gene expression profile correspondent to the GBM subgroup in which there was also an elevated expression of Achaete-scute homolog 1 (ASCL1). This evidence concerns the gene ASCL1 and glioblastoma.